|
Proportions of observed numbers of cases in 1993–97 covered by prediction intervals based on trends up to 1987, by site, sex, country and frequency*. |
|||
| Number of intervals |
Coverage number (%) |
P-value for difference |
|
|
|
|||
| Site |
0.54 |
||
| Lip |
5 |
2 (40) |
|
| Tongue, oral cavity and pharynx |
10 |
5 (50) |
|
| Oesophagus |
10 |
5 (50) |
|
| Stomach |
10 |
5 (50) |
|
| Colon |
10 |
7 (70) |
|
| Rectum |
10 |
5 (50) |
|
| Pancreas |
10 |
6 (60) |
|
| Larynx |
5 |
3 (60) |
|
| Lung |
10 |
4 (40) |
|
| Breast |
5 |
2 (40) |
|
| Cervix uteri |
5 |
2 (40) |
|
| Corpus uteri |
5 |
2 (40) |
|
| Ovary |
5 |
1 (20) |
|
| Prostate |
5 |
2 (40) |
|
| Testis |
5 |
4 (80) |
|
| Kidney |
10 |
7 (70) |
|
| Urinary bladder |
10 |
5 (50) |
|
| Melanoma of the skin |
10 |
3 (30) |
|
| Thyroid |
10 |
7 (70) |
|
| Non-Hodgkin lymphomas |
10 |
4 (40) |
|
| Hodgkin disease |
10 |
9 (90) |
|
| Multiple myeloma |
10 |
4 (40) |
|
| Acute leukaemia |
10 |
7 (70) |
|
| Other sites |
10 |
3 (30) |
|
| Sex |
0.67 |
||
| Male |
100 |
50 (50) |
|
| Female |
100 |
54 (54) |
|
| Country |
<0.001 |
||
| Denmark |
40 |
18 (45) |
|
| Finland |
40 |
21 (53) |
|
| Iceland |
40 |
35 (88) |
|
| Norway |
40 |
20 (50) |
|
| Sweden |
40 |
10 (25) |
|
| Frequency |
<0.001 |
||
| ≤ 70 per year |
50 |
42 (84) |
|
| > 70 and ≤ 230 per year |
50 |
26 (52) |
|
| > 230 and ≤ 555 per year |
50 |
23 (46) |
|
| > 555 per year |
50 |
13 (26) |
|
|
*Average number of cases per year in the period 1983–87, grouped into four quartiles. | |||
Møller et al. BMC Medical Research Methodology 2005 5:21 doi:10.1186/1471-2288-5-21 |
|||